ATLAS / Macro Radar / Reporting / ATNM

Actinium Pharmaceuticals, Inc. (ATNM) reporting calendar

Actinium Pharmaceuticals, Inc. files periodic reports with the SEC as ATNM on NYSE. Atlas tracks 73 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
15 Jul 2026 – 7 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
8 May 2026
Reports on record
73

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 42 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open ATNM market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll NYSE reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20268 May 202638 days0001213900-26-053980
10-K31 Dec 202530 Mar 202689 days0001213900-26-036504
10-Q30 Sep 202514 Nov 202545 days0001213900-25-110979
10-Q30 Jun 20258 Aug 202539 days0001213900-25-073743
10-Q31 Mar 20259 May 202539 days0001213900-25-041614
10-K31 Dec 202431 Mar 202590 days0001213900-25-026371
10-Q30 Sep 202414 Nov 202445 days0001213900-24-098534
10-Q30 Jun 20245 Aug 202436 days0001213900-24-065239
10-Q31 Mar 202426 Apr 202426 days0001213900-24-036699
10-K31 Dec 202329 Mar 202489 days0001213900-24-028038
10-Q30 Sep 20232 Nov 202333 days0001213900-23-082459
10-Q30 Jun 202314 Aug 202345 days0001213900-23-067199
10-Q31 Mar 202315 May 202345 days0001213900-23-039902
10-K31 Dec 202231 Mar 202390 days0001213900-23-025597
10-Q30 Sep 202214 Nov 202245 days0001213900-22-072371
10-Q30 Jun 202212 Aug 202243 days0001213900-22-047496
10-Q31 Mar 202213 May 202243 days0001213900-22-026538
10-K31 Dec 202125 Mar 202284 days0001213900-22-015208
10-Q30 Sep 202112 Nov 202143 days0001213900-21-058783
10-Q30 Jun 202130 Jul 202130 days0001213900-21-039595
10-Q31 Mar 202114 May 202144 days0001213900-21-026493
10-K31 Dec 202031 Mar 202190 days0001213900-21-019297
10-Q30 Sep 202023 Oct 202023 days0001213900-20-033053
10-Q30 Jun 202014 Aug 202045 days0001213900-20-022334
10-Q31 Mar 202029 Jun 202090 days0001213900-20-016168
10-K31 Dec 20198 May 2020129 days0001213900-20-011475
10-Q30 Sep 201912 Nov 201943 days0001213900-19-022937
10-Q30 Jun 20199 Aug 201940 days0001213900-19-015171
10-Q31 Mar 201910 May 201940 days0001213900-19-008291
10-K31 Dec 201815 Mar 201974 days0001213900-19-004269
10-Q30 Sep 20189 Nov 201840 days0001213900-18-015315
10-Q30 Jun 20189 Aug 201840 days0001213900-18-010603
10-Q31 Mar 201810 May 201840 days0001213900-18-005849
10-K31 Dec 201716 Mar 201875 days0001213900-18-003091
10-Q30 Sep 20173 Nov 201734 days0001213900-17-011347
10-Q30 Jun 20174 Aug 201735 days0001213900-17-008244
10-Q31 Mar 201715 May 201745 days0001213900-17-005183
10-K31 Dec 201616 Mar 201775 days0001213900-17-002461
10-Q30 Sep 201628 Oct 201628 days0001213900-16-017787
10-Q30 Jun 201629 Jul 201629 days0001213900-16-015402

Source: SEC EDGAR company submissions for CIK 0001388320. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.